Spots Global Cancer Trial Database for cisplatinum
Every month we try and update this database with for cisplatinum cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma | NCT03215719 | Oropharyngeal C... HPV Positive Or... | Standard Radiat... Dose-Deescalate... Cisplatinum | 18 Years - | NYU Langone Health | |
| Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP | NCT02983097 | Diffuse Large B... Follicular Lymp... Mantle Cell Lym... Burkitt Lymphom... Aggressive Marg... | Rituximab Cisplatin Carboplatin Dexamethasone Cytarabine Lenalidomide PegFilgrastim peripheral stem... | 18 Years - 70 Years | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | |
| Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC | NCT01742767 | NSCLC | Cisplatinum Pemetrexed | 18 Years - 75 Years | Universität Duisburg-Essen | |
| Adaptive Radiation Treatment for Head and Neck Cancer | NCT01504815 | Head and Neck C... | cisplatinum Conventional ra... Adaptive radiot... | 18 Years - 70 Years | The Netherlands Cancer Institute | |
| Adaptive Radiation Treatment for Head and Neck Cancer | NCT01504815 | Head and Neck C... | cisplatinum Conventional ra... Adaptive radiot... | 18 Years - 70 Years | The Netherlands Cancer Institute | |
| Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients | NCT02766348 | NSCLC | gemcitabine DC-CTL cisplatinum | 18 Years - 80 Years | Shenzhen Hornetcorn Bio-technology Company, LTD | |
| Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC | NCT01742767 | NSCLC | Cisplatinum Pemetrexed | 18 Years - 75 Years | Universität Duisburg-Essen | |
| A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) | NCT00301301 | Non-Hodgkins Ly... | Gemcitabine Cisplatinum Rituximab | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | NCT00083538 | Multiple Myelom... | Dexamethasone Thalidomide Cisplatinum Adriamycin Cyclophosphamid... Etoposide | 18 Years - | University of Arkansas | |
| A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) | NCT00301301 | Non-Hodgkins Ly... | Gemcitabine Cisplatinum Rituximab | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC | NCT01742767 | NSCLC | Cisplatinum Pemetrexed | 18 Years - 75 Years | Universität Duisburg-Essen | |
| Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer | NCT02760667 | Head and Neck C... | Cisplatinum Docetaxel Carboplatin Transoral Robot... | 18 Years - | George Washington University | |
| Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | NCT00083538 | Multiple Myelom... | Dexamethasone Thalidomide Cisplatinum Adriamycin Cyclophosphamid... Etoposide | 18 Years - | University of Arkansas | |
| A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) | NCT00301301 | Non-Hodgkins Ly... | Gemcitabine Cisplatinum Rituximab | 18 Years - | Royal Marsden NHS Foundation Trust | |
| PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) | NCT01320254 | Cholangiocarcin... | Cisplatin, Gemc... Cisplatin, Gemc... | 18 Years - | Hannover Medical School | |
| Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance | NCT02896582 | Mantle Cell Lym... | Obinutuzumab Dexamethasone Aracytine Cisplatinum Etoposide Melphalan Carmustine | 18 Years - 65 Years | The Lymphoma Academic Research Organisation | |
| Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer | NCT02760667 | Head and Neck C... | Cisplatinum Docetaxel Carboplatin Transoral Robot... | 18 Years - | George Washington University | |
| Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer | NCT02760667 | Head and Neck C... | Cisplatinum Docetaxel Carboplatin Transoral Robot... | 18 Years - | George Washington University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
